MX2017004876A - Proceso para preparar un eritritol directamente comprimible y usos de este. - Google Patents

Proceso para preparar un eritritol directamente comprimible y usos de este.

Info

Publication number
MX2017004876A
MX2017004876A MX2017004876A MX2017004876A MX2017004876A MX 2017004876 A MX2017004876 A MX 2017004876A MX 2017004876 A MX2017004876 A MX 2017004876A MX 2017004876 A MX2017004876 A MX 2017004876A MX 2017004876 A MX2017004876 A MX 2017004876A
Authority
MX
Mexico
Prior art keywords
preparing
directly compressible
erythritol
compressible erythritol
directly
Prior art date
Application number
MX2017004876A
Other languages
English (en)
Other versions
MX371188B (es
Inventor
Patricia L Boghmans Catherine
Wilhelmus Hubertus Antonius De Cock Petrus
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of MX2017004876A publication Critical patent/MX2017004876A/es
Publication of MX371188B publication Critical patent/MX371188B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporciona un proceso para preparar una composición de eritritol directamente comprimible que es adecuada para la fabricación de comprimidos. La composición incluye un agente aglutinante, tal como maltodextrina.
MX2017004876A 2014-10-16 2015-10-16 Proceso para preparar un eritritol directamente comprimible y usos de este. MX371188B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462064811P 2014-10-16 2014-10-16
PCT/US2015/055987 WO2016061486A1 (en) 2014-10-16 2015-10-16 Process for preparing a directly compressible erythritol & uses thereof

Publications (2)

Publication Number Publication Date
MX2017004876A true MX2017004876A (es) 2017-07-05
MX371188B MX371188B (es) 2020-01-22

Family

ID=55747415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004876A MX371188B (es) 2014-10-16 2015-10-16 Proceso para preparar un eritritol directamente comprimible y usos de este.

Country Status (7)

Country Link
US (1) US10463620B2 (es)
EP (1) EP3206671A4 (es)
JP (1) JP6718866B2 (es)
AU (1) AU2015331870B2 (es)
CA (1) CA2963706C (es)
MX (1) MX371188B (es)
WO (1) WO2016061486A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016429743B2 (en) * 2016-11-18 2020-10-08 Fertin Pharma A/S Oral delivery vehicle
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
MX2019005828A (es) * 2016-11-18 2019-07-08 Fertin Pharma As Tableta que comprende aglutinante y eritritol separados.
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
JP2020023449A (ja) * 2018-08-07 2020-02-13 物産フードサイエンス株式会社 エリスリトールを有効成分とする組成物、これを用いる錠剤の製造方法および錠剤
CN115462495A (zh) * 2022-09-06 2022-12-13 江苏艾兰得营养品有限公司 一种微泡腾片及其制备方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100009D0 (en) * 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
GB9109125D0 (en) 1991-04-27 1991-06-12 Cerestar Holding Bv Sweetening composition
JPH0735348B2 (ja) 1991-07-30 1995-04-19 日研化学株式会社 エリスリトール結晶の乾燥法
JPH0778126B2 (ja) 1992-02-10 1995-08-23 日清紡績株式会社 多糖類真球状粒子及び製造方法
DE19615418A1 (de) 1996-04-22 1997-10-23 Merck Patent Gmbh Polyol-Zusammensetzung
WO1998002185A1 (fr) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Materiaux moules par compression, a desagregation rapide, et leur procede de production
JP2003176242A (ja) 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
HUP0000279A3 (en) 1996-11-15 2002-07-29 Merck Patent Gmbh Method for producing shaped and unshaped polyol masses
WO2000048575A1 (fr) 1999-02-17 2000-08-24 Kyowa Hakko Kogyo Co., Ltd. Comprimes et procede de production de comprimes
DE19943491B4 (de) * 1999-09-10 2010-04-01 Südzucker AG Mannheim/Ochsenfurt Verbesserte Komprimate
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
WO2002070013A1 (fr) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Utilisation d'une poudre sechee par atomisation contenant un alcool de sucre
CA2440361A1 (en) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
FR2822646B1 (fr) 2001-03-30 2005-03-11 Roquette Freres Edulcorants de table enrichis en fibres
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
GB0217076D0 (en) 2002-07-23 2002-08-28 Mars Inc Foodstuff
US7338677B2 (en) 2002-08-14 2008-03-04 Wm. Wrigley Jr. Company Methods for manufacturing coated confectionary products
US7378118B2 (en) 2002-08-14 2008-05-27 Wm. Wrigley Jr. Company Methods for manufacturing coated confectionary products
WO2004089343A1 (en) 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Water soluble tablets
US20070092562A1 (en) 2003-10-28 2007-04-26 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
US20070082104A1 (en) 2004-08-12 2007-04-12 Sophie De Baets Functional sugar replacement
JP2006265242A (ja) 2005-02-28 2006-10-05 Dai Ichi Seiyaku Co Ltd 口腔内速崩壊性医薬用組成物およびその製造方法
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
JP5209492B2 (ja) 2005-12-21 2013-06-12 ビーエーエスエフ ソシエタス・ヨーロピア 速崩性錠剤製造のための医薬製剤
US20100093875A1 (en) 2006-10-25 2010-04-15 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
WO2008076361A2 (en) 2006-12-14 2008-06-26 Archer-Daniels-Midland Company Animal feeds containing polyols
ES2302650B1 (es) * 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
AU2008216453B2 (en) 2007-02-12 2011-07-28 Wm. Wrigley Jr. Company Coated confectionery products
EP1977734A1 (en) 2007-04-03 2008-10-08 Royal College of Surgeons in Ireland A method of producing fast dissolving tablets
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
WO2009135946A1 (en) 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
WO2010092828A1 (ja) 2009-02-12 2010-08-19 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
BRPI1009824B1 (pt) 2009-03-09 2020-02-18 Spi Pharma, Inc. Forma de farmacêutica sólida compreendendo uma dispersão altamente compactável e durável incluindo carboidratos co-processados
MX2012001893A (es) 2009-08-18 2012-03-16 Cargill Inc Tableteado de eritritol e isomaltosa.
WO2011066428A1 (en) 2009-11-25 2011-06-03 Cargill, Incorporated Sweetener compositions and methods of making the same
CN102933093A (zh) 2010-05-03 2013-02-13 嘉吉公司 用于食品的包括赤藓糖醇和填充剂的低热和无糖涂覆物
JP5973347B2 (ja) 2010-08-31 2016-08-23 協和発酵キリン株式会社 口腔内崩壊錠
EP2457554A1 (de) * 2010-11-24 2012-05-30 Symrise AG Menthol enthaltende Mischung
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
US10681929B2 (en) 2012-02-17 2020-06-16 Conagra Foods Rdm, Inc. Food product and coating
JP6061768B2 (ja) 2013-04-19 2017-01-18 マイクロフーズジャパン株式会社 直打用エリスリトール球形顆粒及びその製造方法並びに該エリスリトール顆粒を薬効成分又は栄養成分とともに打錠する製造方法及びその製造方法で得られた錠剤または一般飲食錠菓

Also Published As

Publication number Publication date
AU2015331870A1 (en) 2017-04-27
JP6718866B2 (ja) 2020-07-08
JP2017531017A (ja) 2017-10-19
AU2015331870B2 (en) 2020-07-23
US20170304206A1 (en) 2017-10-26
US10463620B2 (en) 2019-11-05
EP3206671A1 (en) 2017-08-23
MX371188B (es) 2020-01-22
CA2963706C (en) 2023-10-03
WO2016061486A1 (en) 2016-04-21
CA2963706A1 (en) 2016-04-21
EP3206671A4 (en) 2018-06-13

Similar Documents

Publication Publication Date Title
MX2017004876A (es) Proceso para preparar un eritritol directamente comprimible y usos de este.
CL2016002772A1 (es) Composiciones de insulina de rápida acción
PT3456717T (pt) Derivado de 4,6-diamino-quinolina-3-carbonitrilo como modulador do cancro da tiróide de osaka (cot) para o tratamento de doenças inflamatórias
GEP20217239B (en) Pharmaceutical composition
EP3199210A4 (en) Leg press
MX2017002538A (es) Absorbedor para unión de metales y la producción del mismo.
ZA201505261B (en) Sulphur-based fertilizer compositions
MX365494B (es) Procedimiento de compuesto antifungico.
MX2016012053A (es) Procedimiento de compuesto antifungico.
GEP20217240B (en) Pharmaceutical composition
HK1232218A1 (zh) -活性化合物的片劑製劑
MX2017001487A (es) Sofosbuvir en forma cristalina y proceso para su preparacion.
IN2014MU00455A (es)
MX2017011389A (es) Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos.
MX2021000508A (es) Extracto de sabadilla seco y fluido.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
EA201691924A1 (ru) Фармацевтические композиции
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique
EP3508223A4 (en) COMPOSITION FOR ACTIVATING NEUROGENESIS
MY180413A (en) Process for the decomposition of lignocellulose-containing biomass-material
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2016016397A (es) Proceso para preparar 3-cloro-2-vinilfenol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2016014255A (es) Producto ceramico refractario.
MX2021000509A (es) Extracto concentrado de sabadilla.

Legal Events

Date Code Title Description
FG Grant or registration